Glenmark Pharmaceuticals receives USFDA tentative nod for anti-asthma tablets – Economic Times


Moneycontrol.com

Glenmark Pharmaceuticals receives USFDA tentative nod for anti-asthma tablets
Economic Times
NEW DELHI: Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator to market its generic Montelukast Sodium tablets used for treating asthma and seasonal allergies. Glenmark Generics Inc has received
Glenmark gets tentative US FDA nod for asthma drugMoneycontrol.com
Glenmark Generics gets Tentative USFDA nod for Montelukast Sodium 10 mg tabletsEquity Bulls

all 2 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.